Form 4: Leidos Holdings Executive Carly Elizabeth Kimball Reports Stock Option Grant
SEC Form 4 Filing
Carly Elizabeth Kimball, Chief Performance Officer of Leidos Holdings, reports the acquisition of 6,320 stock options.
Summary
- Carly Elizabeth Kimball, Chief Performance Officer of Leidos Holdings, filed a Form 4 on March 12, 2024, reporting a transaction on March 8, 2024.
- The transaction involved the acquisition of 6,320 stock options with an exercise price of $129.79.
- These options vest in three annual installments starting March 8, 2025, and expire on March 7, 2031.
- Following the reported transaction, Kimball directly owns 6,320 derivative securities (stock options).
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating a stable and incentivized management structure. This is generally viewed positively.
Positives
- The grant of stock options to a key executive aligns their interests with those of the shareholders.
Industry Context
Stock option grants are a common form of executive compensation in publicly traded companies, particularly in the technology and defense sectors where Leidos operates. They are used to incentivize performance and align executive interests with shareholder value.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the technology and defense industries.
- Companies like Lockheed Martin, Northrop Grumman, and General Dynamics also utilize stock options as part of their executive compensation plans.
- The vesting schedule of three annual installments is a typical vesting structure.
Stakeholder Impact
- The stock option grant incentivizes the Chief Performance Officer to improve company performance, which benefits shareholders.
- The grant does not have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Date of stock option grant |
| 03/08/2025 | First vesting date of the stock options |
| 03/07/2031 | Expiration date of the stock options |
| 03/12/2024 | Form 4 filing date |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.